Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis

Hepatology

Volumn 28, Issue 3, 1998, Pages 660-662

  Moloney, Manus M ^a   Thomson, Linda J ^a   Strettell, Michael J ^a   Williams, Roger ^a   Donaldson, Peter T ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; EUROPE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; TELOMERE;

EID: 0031752377     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280309     Document Type: Article

References (23)

1. Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982;17:187-191.
2. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut 1983;24:38-41.
3. Prochazka EJ, Terasaki P, Park MS, Goldstein LI, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 1990;322:1842-1844.
4. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. HEPATOLOGY 1991;13:129-133.
5. Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Welsh KI, Eddleston AL, et al. Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. HEPATOLOGY 1992;16:390-395.
6. Mehal WZ, Lo YM, Wordsworth BP, Neuberger JM, Hubscher SC, Fleming KA, Chapman RW. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroemerology 1994;106:160-167.
7. Olerup O, Olsson R, Hultcrantz R, Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroemerology 1995;108:870-878.
8. Bunce M, Welsh KI. Rapid DNA typing for HLA-C using sequencespecific primers (PCR-SSP): Identification of serological and nonserologically defined HLA-C alleles including several new alleles. Tissue Antigens 1994;43:7-17.
9. Bunce M, Barnardo MC, Welsh KI. Improvements in HLA-C typing using sequence-specific primers (PCR-SSP) including definition of HLA-Cw9 and Cwl0 and a new allele HLA-"Cw7/8v." Tissue Antigens 1994;44:200-203.
10. Bunce M, Barnardo MCNM, Proctor J, Marsh SGE, Vilches C, Welsh KI. High resolution HLA-C typing by PCR-SSP: Identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK caucasoids and a comparison with serology. Tissue Antigens 1996;48:680-691.
11. Bunce M, Barnardo MCNM, Proctor J, Marsh SGE, Vilches C, Welsh KI. High resolution HLA-C typing by PCR-SSP: Identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK caucasoids and a comparison with serology. Tissue Antigens 1997;50:100-111.
12. Strettell MDJ, Thomson LJ, Donaldson PT, Bunce M, O'Neill CM, Williams R. HLA-C genes and susceptibility to type 1 autoimmune hepatitis. HEPATOLOGY 1997;26:1023-1026.
13. Baur MP, Neugebaur M, Albert ED. Reference tables for two locus haplotype frequencies for all MHC marker loci. In: Albert ED, Baur MP, Mayr WR, eds. Histocompatibility Testing. Berlin: Springer-Verlag, 1984:677-755.
14. Baur MP, Neugebaur M, Albert ED. Reference tables for three locus haplotype frequencies and delta values in Caucasians, Orientals and Negroids. In: Albert ED, Baur MP, Mayr WR, eds. Histocompatibility Testing. Berlin: Springer-Verlag, 1984:756-757.
15. Tiwari JL, Terasaki PI. The Data and Statistical Analysis. HLA and Disease Associations. New York: Springer Verlag, 1985:18-25.
16. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;332:924-933.
17. Strettell MD, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, Williams R. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroemerology 1997;112:2028-2035.
18. Todd JA, Bell JI, McDevitt HO. HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329:599-604.
19. Colonna M, Spies T, Strominger JL, Ciccone E, Moretta A, Moretta L, Pende D, et al. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci U S A 1992;89:7983-7985.
20. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, et al. Amino acid substitutions can influence the natural killer (NK)mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 1995;182:605-609.
21. Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996;17:86-91.
22. Lanier LL, Phillips JH. NK cell recognition of major histocompatibility complex class I molecules. Semin Immunol 1995;7:75-82.
23. Phillips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995;268:403-405.